Skip to main content

Table 3 Baseline patient characteristics

From: Correlation between the efficacy of stem cell therapy for osteonecrosis of the femoral head and cell viability

Variable

Group A (N = 16)

Group B (N = 14)

p value

Side of treated hip

 Left (%)

10 (62.5%)

6 (42.9%)

>  0.05

 Right (%)

6 (37.5%)

8 (57.1%)

>  0.05

Age (mean ± SD)

30.69 ± 5.87

30.43 ± 4.45

>  0.05

Gender (male/female)

10/6

9/5

>  0.05

Preoperative HHS (mean ± SD)

68.67 ± 8.38

75.01 ± 6.37

>  0.05

Preoperative necrotic area ratio (%)

34.17 ± 9.01

37.05 ± 10.29

>  0.05

MNC concentration (× 109/L, mean ± SD)

9.94 ± 1.46

10.04 ± 1.47

>  0.05

Hospitalization expense ($)

3203.31 ± 115.23

3190.14 ± 134.37

>  0.05

  1. No variables were significantly different between groups A and B at baseline